Annual report [Section 13 and 15(d), not S-K Item 405]

DESCRIPTION OF BUSINESS (Details Narrative)

v3.25.1
DESCRIPTION OF BUSINESS (Details Narrative)
12 Months Ended
Dec. 31, 2024
US [Member]  
Description Of Business [Line Items]  
Orphan drug designation provides marketing exclusivity period 7 years